Determination of growth fraction index in mammary carcinoma using MIB-1 monoclonal antibody: estimation of whole tumor proliferative potential using biopsy specimens.
Koji Oda(Tokyo Metropolitan University), Seigo Kishikawa, Makoto Shibuya(The University of Tokyo), Satoshi Kamiya, Noriji Niinomi, Minoru Horisawa(Anjo Kosei Hospital), Shunpei Yokoi(Anjo Kosei Hospital), M. Suzuki(Nova Southeastern University), S. Hayakawa, Hiroshi Kanda(Kyoto University)
PubMed
July 1, 1995
Cited by 2
Related Papers
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience
|Journal of Hepato-Biliary-Pancreatic Surgery|2000|396
Intraductal papillary neoplasia of the liver associated with hepatolithiasis
|Hepatology|2001|282
<scp>l</scp>‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth
|Cancer Science|2009|271
Management of Hilar Cholangiocarcinoma
|Annals of Surgery|2000|259
Surgical Anatomy of the Bile Ducts at the Hepatic Hilum as Applied to Living Donor Liver Transplantation
|Annals of Surgery|2003|203